Mike Bunker

C. R. Bard, Inc. engages in designing, development, manufacturing, packaging, distribution, and sales of medical, surgical, diagnostic, and patient care devices. It sells its products to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. The company was founded by Charles Russell Bard in 1907 and is headquartered in Franklin Lakes, NJ.

Intellirod Spine, Inc. develops a wireless implantable microelectronic lumbar spine fusion sensor. Its strain monitoring system allows spine surgeons to assess the strain on implanted spinal fusion rods and provide evidence of rod loads indicative of loosening or increased load sharing as fusion progresses. The firm’s intellirod system provides postoperative data complementing surgeon data currently collected from flexion extension x-rays and costly high radiation CT scans. The company was founded by William P. Hnat, John F. Naber, Rolando M. Puno, Michael Voor and Kevin M. Walsh in 2003 and is headquartered in Akron, OH.

CardioX, Inc. develops technology to detect heart defects. It commercializes a non-invasive method for detecting the presence of a right-to-left cardiac shunt to enable closure before the occurrence of a debilitating or life threatening stroke. The company was founded by Philip E. Eggers in June 1996 and is headquartered in Columbus, OH.

HistoSonics, Inc. develops medical devices. The company was founded by Christine Gibbons, Jim Bertolina, Zhen Xu, William Robert, Hall Timothy, J. Brian Fowlkes, Thomas W. Davison, and Charles Cain in November 2009 and is headquartered in Ann Arbor, MI.

Rand McNally & Co. provided products and services for the trucking, commercial transportation and education market. It offered IntelliRoute, a truck routing software and GPS devices, a geography-based online subscription service for schools, printed maps and atlases. The company was founded by Pete M. Stiles, Andrew McNally III, and William H. Rand and was headquartered in Skokie, IL.

Early Stage Partners (Early Stage Partners) is a venture capital firm founded in 2001 by Jonathan Murray. The firm is headquartered in Cleveland, Ohio.

Juventas Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. It is a clinical-stage biotechnology company developing a pipeline of factor-based regenerative therapies to treat life-threatening diseases. The company's product has been shown to protect and repair tissue following ischemic injury by recruiting the body's own stem cells to the damaged tissue. The company was founded by Rahul A. Aras and Marc S. Penn in 2007 and is headquartered in Cleveland, OH.

Prevacept Infection Control, Inc. develops and designs pharmaceutical products to eliminate microbial infections. The firm offers B-Lock, an anti-coagulant catheter lock solution with broad spectrum activity against bacterial and fungal microorganisms known to form bio-film structures in indwelling catheters. The company was founded by Krzysztof Appelt and Thomas I. Bradshaw in 2006 and is headquartered in Broomfield, CO.